Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy.
Yu Y, Bogdan M, Noman MZ, Parpal S, Bartolini E, Van Moer K, Kleinendorst SC, Bilgrav Saether K, Trésaugues L, Silvander C, Lindström J, Simeon J, Timson MJ, Al-Hashimi H, Smith BD, Flynn DL, Alexeyenko A, Viklund J, Andersson M, Martinsson J, Pokrovskaja Tamm K, De Milito A, Janji B.
Yu Y, et al. Among authors: flynn dl.
Mol Oncol. 2024 Mar 20. doi: 10.1002/1878-0261.13619. Online ahead of print.
Mol Oncol. 2024.
PMID: 38506049
Free article.